These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25823974)

  • 21. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
    Kohno Y; Yamamoto H; Hirahashi M; Kumagae Y; Nakamura M; Oki E; Oda Y
    Hum Pathol; 2016 Jun; 52():145-52. PubMed ID: 26980051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
    Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
    Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological features and prognosis of Borrmann type IV gastric cancer.
    Zhu YL; Yang L; Sui ZQ; Liu L; Du JF
    J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
    Korourian A; Roudi R; Shariftabrizi A; Madjd Z
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
    Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
    J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node metastasis as a single predictor in patients with Borrmann type I gastric cancer.
    Chen JH; Wu CW; Lo SS; Li AF; Hsieh MC; Shen KH; Lui WY
    Hepatogastroenterology; 2007; 54(75):981-4. PubMed ID: 17591108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive mutation profiling of mucinous gastric carcinoma.
    Rokutan H; Hosoda F; Hama N; Nakamura H; Totoki Y; Furukawa E; Arakawa E; Ohashi S; Urushidate T; Satoh H; Shimizu H; Igarashi K; Yachida S; Katai H; Taniguchi H; Fukayama M; Shibata T
    J Pathol; 2016 Oct; 240(2):137-48. PubMed ID: 27313181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of lymph node metastasis in mixed-type early gastric cancer determined by the extent of the poorly differentiated component.
    Hwang CS; Ahn S; Lee BE; Lee SJ; Kim A; Choi CI; Kim DH; Jeon TY; Kim GH; Song GA; Park DY
    World J Gastroenterol; 2016 Apr; 22(15):4020-6. PubMed ID: 27099445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.
    Fang WL; Huang KH; Lan YT; Lin CH; Chang SC; Chen MH; Chao Y; Lin WC; Lo SS; Li AF; Wu CW; Chiou SH; Shyr YM
    Oncotarget; 2016 Feb; 7(5):6201-20. PubMed ID: 26701847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleotide variants within the IQGAP1 gene in diffuse-type gastric cancers.
    Morris LE; Bloom GS; Frierson HF; Powell SM
    Genes Chromosomes Cancer; 2005 Mar; 42(3):280-6. PubMed ID: 15611933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variegated RHOA mutations in human cancers.
    Kataoka K; Ogawa S
    Exp Hematol; 2016 Dec; 44(12):1123-1129. PubMed ID: 27693615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.
    Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580
    [No Abstract]   [Full Text] [Related]  

  • 34. Frequent
    Tanaka A; Ishikawa S; Ushiku T; Yamazawa S; Katoh H; Hayashi A; Kunita A; Fukayama M
    Oncotarget; 2018 Jun; 9(50):29336-29350. PubMed ID: 30034621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
    Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
    Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
    Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exome sequencing of gastric cancers screened the differences of clinicopathological phenotypes between the mutant and the wide-type of frequently mutated genes].
    Cong T; Liu GX; Cui JX; Zhang KC; Chen ZD; Chen L; Wei B; Huang XH
    Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(28):2242-2245. PubMed ID: 30078278
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characteristics of clinical early gastric cancer in the upper-third stomach.
    Ichikawa D; Komatsu S; Kosuga T; Konishi H; Okamoto K; Shiozaki A; Fujiwara H; Otsuji E
    World J Gastroenterol; 2015 Dec; 21(45):12851-6. PubMed ID: 26668509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.